These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 37196470)
1. The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer. Doghish AS; El-Husseiny AA; Abdelmaksoud NM; El-Mahdy HA; Elsakka EGE; Abdel Mageed SS; Mahmoud AMA; Raouf AA; Elballal MS; El-Dakroury WA; AbdelRazek MMM; Noshy M; El-Husseiny HM; Abulsoud AI Pathol Res Pract; 2023 Jun; 246():154529. PubMed ID: 37196470 [TBL] [Abstract][Full Text] [Related]
2. An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer. Fathi D; Elballal MS; Elesawy AE; Abulsoud AI; Elshafei A; Elsakka EGE; Ismail A; El-Mahdy HA; Elrebehy MA; Doghish AS Life Sci; 2023 Jun; 322():121667. PubMed ID: 37023952 [TBL] [Abstract][Full Text] [Related]
3. Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer. Ashrafizadeh M; Hushmandi K; Hashemi M; Akbari ME; Kubatka P; Raei M; Koklesova L; Shahinozzaman M; Mohammadinejad R; Najafi M; Sethi G; Kumar AP; Zarrabi A Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784711 [TBL] [Abstract][Full Text] [Related]
4. The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay. Hegazy M; Elkady MA; Yehia AM; Elsakka EGE; Abulsoud AI; Abdelmaksoud NM; Elshafei A; Abdelghany TM; Elkhawaga SY; Ismail A; Mokhtar MM; El-Mahdy HA; Doghish AS Pathol Res Pract; 2023 Jun; 246():154510. PubMed ID: 37167812 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway. Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594 [TBL] [Abstract][Full Text] [Related]
6. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway. Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788 [TBL] [Abstract][Full Text] [Related]
7. The Wnt/β-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation. Song Y; Li ZX; Liu X; Wang R; Li LW; Zhang Q Tumour Biol; 2017 Jul; 39(7):1010428317712617. PubMed ID: 28671020 [TBL] [Abstract][Full Text] [Related]
8. miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer. Sun Y; Yu X; Bai Q Int J Clin Exp Pathol; 2015; 8(10):12775-83. PubMed ID: 26722467 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2. Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer. Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-1275 induces radiosensitization in oesophageal cancer by regulating epithelial-to-mesenchymal transition via Wnt/β-catenin pathway. Xie C; Wu Y; Fei Z; Fang Y; Xiao S; Su H J Cell Mol Med; 2020 Jan; 24(1):747-759. PubMed ID: 31733028 [TBL] [Abstract][Full Text] [Related]
12. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review. Elrebehy MA; Al-Saeed S; Gamal S; El-Sayed A; Ahmed AA; Waheed O; Ismail A; El-Mahdy HA; Sallam AM; Doghish AS Int J Biol Macromol; 2022 Aug; 214():583-600. PubMed ID: 35768045 [TBL] [Abstract][Full Text] [Related]
13. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis. Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853 [TBL] [Abstract][Full Text] [Related]
14. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance. Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812 [TBL] [Abstract][Full Text] [Related]
15. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition]. Yuki R Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542 [TBL] [Abstract][Full Text] [Related]
16. Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells. Ning X; Wang C; Zhang M; Wang K Oncol Res; 2019 Mar; 27(4):399-406. PubMed ID: 29426374 [TBL] [Abstract][Full Text] [Related]
17. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling. Zhang JX; Mai SJ; Huang XX; Wang FW; Liao YJ; Lin MC; Kung HF; Zeng YX; Xie D Ann Oncol; 2014 Nov; 25(11):2196-2204. PubMed ID: 25193986 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3. Yang C; Shen S; Zheng X; Ye K; Sun Y; Lu Y; Ge H FASEB J; 2019 Sep; 33(9):10490-10504. PubMed ID: 31311326 [TBL] [Abstract][Full Text] [Related]
19. Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer. Koleckova M; Ehrmann J; Bouchal J; Janikova M; Brisudova A; Srovnal J; Staffova K; Svoboda M; Slaby O; Radova L; Vomackova K; Melichar B; Veverkova L; Kolar Z Sci Rep; 2021 Mar; 11(1):5145. PubMed ID: 33664322 [TBL] [Abstract][Full Text] [Related]